PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell

Zha, HL; Xu, ZX; Xu, XC; Lu, XY; Shi, PL; Xiao, YM; Tsai, HI; Su, DD; Cheng, F; Cheng, XL; Chen, HB

Cheng, F; Chen, HB (通讯作者)，Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Shenzhen Campus, Shenzhen 518107, Peoples R China.;Cheng, F; Cheng, XL (通讯作者)，Shenzhen Baoan Maternal & Child Hlth Hosp, Dept Pharm, Shenzhen 518133, Peoples R China.

PHARMACEUTICS, 2022; 14 (6):

Abstract

PD-1 inhibitor Keytruda combined with chemotherapy for Triple-negative breast cancer (TNBC) has been approved for FDA, successfully representing the c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索